tiprankstipranks
Terns Pharmaceuticals initiated with an Outperform at Oppenheimer
The Fly

Terns Pharmaceuticals initiated with an Outperform at Oppenheimer

Oppenheimer initiated coverage of Terns Pharmaceuticals (TERN) with an Outperform rating and $82 price target

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App